Tenofovir alafenamide for HBV Patients

We need to tenofovir alafenamide for HBV patients now in Iran! The US Food and Drug Administration has approved tenofovir alafenamide (TAF) 25 mg once daily, for treatment of adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Tenofovir disoproxil fumarate (TDF) has potent antiviral activity in…

Read More

Happy New Year

The New Year brings with itself a fresh start, new opportunities and an exhilarating sense of rejuvenation. We often make New Year’s resolutions in an attempt to improve ourselves and to be better towards others and we wish everyone success and a healthy long life as well. As an Iranian doctor,…

Read More

Hepatitis C ‘eradicated’ among haemophiliacs

December 23, 2016 It is a great achievement for Ireland that hepatitis C has virtually been eradicated in people who have haemophilia, according to Health Minister Simon Harris. “I am so delighted for all the patients, who can now look forward to a bright, healthy future,” says Mr Harris. All…

Read More

Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis

Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis has published recently in Hepat Mon by Alavian et al: Abstract Context: Direct acting antivirals (DAAs) have recently emerged as a promising therapeutic regimen for the treatment of hepatitis C virus (HCV) infection, which is a major…

Read More

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline has published recently in Hepat Mon by Alavian et al:  Abstract Context: Hepatitis C virus (HCV) infection is a major public health issue worldwide, including Iran. The new direct-acting antiviral agents (DAAs) with high efficacy have…

Read More

Nice Article from Thailand about coverage of HCV treatment

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era. By Poovorawan K et al in:  PLoS One. 2016 Sep 15;11(9):e0163095. doi: 10.1371/journal.pone.0163095. Abstract Hepatitis C virus (HCV) infection is an important worldwide public health problem, and most of the…

Read More